Rating History for Rapt Therapeutics (RAPT) by Barclays

More Stocks Rated by Barclays | Latest Ratings for RAPT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/21/2026 Etzer Darout Downgrade Equalweight
(Overweight)		 58.00
(N/A)		 57.57
(58.02)		 0.78% Details